Martin Hubert Kang

Title: Martin Hubert Kang: Innovator in Gene Therapy

Introduction

Martin Hubert Kang is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of gene therapy, particularly through his innovative work on adeno-associated virus particles.

Latest Patents

Kang holds a patent for an "Adeno-associated virus particle with mutated capsid and methods of use thereof." This patent describes a recombinant adeno-associated virus (rAAV) particle featuring a mutated capsid protein. The disclosure provides methods for delivering therapeutic agents to various cells, including muscle, airway, liver, central nervous system, retina, or lung cells in a subject. Additionally, it outlines methods for treating or preventing infectious, acquired, or genetic diseases using the rAAV particle. He has 1 patent to his name.

Career Highlights

Throughout his career, Martin has worked with esteemed institutions such as the University of Guelph and the Ottawa Hospital Research Institute. His work has been pivotal in advancing the understanding and application of gene therapy techniques.

Collaborations

Kang has collaborated with notable colleagues, including Sarah Wootton and Laura Van Lieshout, contributing to a dynamic research environment that fosters innovation.

Conclusion

Martin Hubert Kang is a distinguished inventor whose work in gene therapy continues to impact the medical field. His innovative approaches and collaborations highlight the importance of research in developing effective treatments for various diseases.